Abstract：
OBJECTIVE: The purpose of this study was to explore the existing literature on the relationship between depressive symptoms and executive function in patients with type 1 diabetes (T1DM) across the lifespan.
METHODS: The scoping review followed the PRISMA protocol by using three databases: PubMed, CINAHL, and PsycINFO on May 14, 2023. Primary research that included reported executive function and the association with depressive symptoms was included in the review.
RESULTS: Of 1470 de-duplicated publications identified, nine articles were included in the review. Five studies evaluated the T1DM population, while four studies evaluated T1DM and type 2 diabetes (T2DM) as an aggregate result. Three studies indicated an association between depressive symptoms and executive function in adults with T1DM, and four studies indicated an association between depressive symptoms and executive function in adults with either T1DM or T2DM. In general, participants who reported depressive symptoms also exhibited poor executive function. However, two studies did not find an association between depressive symptoms and executive function.
CONCLUSIONS: In summary, the seven studies in this review suggest that individuals with T1DM who report depressive symptoms are at a higher risk of poor executive function; a clear association between depressive symptoms and executive function in individuals with T1DM remains inconclusive. There is a need to explore this relationship in the future.
METHODS: The scoping review followed the PRISMA protocol by using three databases: PubMed, CINAHL, and PsycINFO on May 14, 2023. Primary research that included reported executive function and the association with depressive symptoms was included in the review.
RESULTS: Of 1470 de-duplicated publications identified, nine articles were included in the review. Five studies evaluated the T1DM population, while four studies evaluated T1DM and type 2 diabetes (T2DM) as an aggregate result. Three studies indicated an association between depressive symptoms and executive function in adults with T1DM, and four studies indicated an association between depressive symptoms and executive function in adults with either T1DM or T2DM. In general, participants who reported depressive symptoms also exhibited poor executive function. However, two studies did not find an association between depressive symptoms and executive function.
CONCLUSIONS: In summary, the seven studies in this review suggest that individuals with T1DM who report depressive symptoms are at a higher risk of poor executive function; a clear association between depressive symptoms and executive function in individuals with T1DM remains inconclusive. There is a need to explore this relationship in the future.
摘要：
目的：本研究的目的是探讨1型糖尿病（T1DM）患者在整个生命周期中抑郁症状与执行功能之间关系的现有文献。
方法：范围审查遵循PRISMA协议，使用三个数据库：PubMed，CINAHL,和PsycINFO于2023年5月14日。主要研究包括报告的执行功能和与抑郁症状的关联。
结果：在确定的1470个去重复出版物中，审查中包括了九篇文章。五项研究评估了T1DM人群，虽然四项研究评估了T1DM和2型糖尿病（T2DM）的综合结果。三项研究表明，成人T1DM患者的抑郁症状与执行功能之间存在关联，4项研究表明成人T1DM或T2DM患者的抑郁症状与执行功能之间存在关联。总的来说,报告有抑郁症状的参与者也表现出不良的执行功能.然而,两项研究未发现抑郁症状与执行功能之间存在关联.
结论：总之，本综述中的7项研究表明,报告有抑郁症状的T1DM患者发生执行功能不良的风险较高;在T1DM患者中,抑郁症状与执行功能之间的明确关联仍无定论.未来有必要探索这种关系。
方法：范围审查遵循PRISMA协议，使用三个数据库：PubMed，CINAHL,和PsycINFO于2023年5月14日。主要研究包括报告的执行功能和与抑郁症状的关联。
结果：在确定的1470个去重复出版物中，审查中包括了九篇文章。五项研究评估了T1DM人群，虽然四项研究评估了T1DM和2型糖尿病（T2DM）的综合结果。三项研究表明，成人T1DM患者的抑郁症状与执行功能之间存在关联，4项研究表明成人T1DM或T2DM患者的抑郁症状与执行功能之间存在关联。总的来说,报告有抑郁症状的参与者也表现出不良的执行功能.然而,两项研究未发现抑郁症状与执行功能之间存在关联.
结论：总之，本综述中的7项研究表明,报告有抑郁症状的T1DM患者发生执行功能不良的风险较高;在T1DM患者中,抑郁症状与执行功能之间的明确关联仍无定论.未来有必要探索这种关系。
